Toggle Nav
My Cart
Search
Advanced Search
Menu
Account
Settings

Western European Molecular Diagnostics Market, 2015 Forecast to 2020

Western European Molecular Diagnostics Market, 2015 Forecast to 2020

Prevalence and Prevention Driving Healthcare in Europe Toward Molecular Diagnostics Expansion and Innovation

RELEASE DATE
02-Jan-2017
REGION
North America
Research Code: MC62-01-00-00-00
SKU: LS00269-NA-MR_19374
AvailableYesPDF Download
$4,950.00
In stock
SKU
LS00269-NA-MR_19374
$4,950.00
DownloadLink
Add to Compare
ENQUIRE NOW

Description

Across all segments of in-vitro diagnostics, including research and further upcoming disruptive technologies across the life sciences landscape—research tools, clinical diagnostics, and pharma—disruptive technologies transform the complete healthcare decision making and diagnostics trend. However, to take advantage of these opportunities and maintain a competitive advantage, life science companies must be able to develop a thorough holistic understanding of areas outside their own expertise to leverage the cross-functional trends and synergistic growth opportunities that are available. Molecular diagnostics companies that fail to capitalize on the opportunities presented through emerging trends and disruptive new business models become late entrants in a market, generally before redundancy from me-too products occurs and take market share. This study provides an elaborate structure of the European healthcare system , which is supporting the growth of molecular diagnostics, the reimbursement strategies, and policies promoting the acceptance of MDx assays across applications. This information would be suitable to understand the current need and the diagnostics style adoption among the patient population for better outcomes and clinical decision making. Specific challenges shared in this study include the shifting payment landscape which pays for services, change in business models, and challenges in innovative therapeutics and molecular diagnostics to align with value-based care models.

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Market Snapshot

Executive summary

Scope and Segmentation

Executive Summary—Market Engineering Measurements

Big Market Directions in Molecular Diagnostics

Market Definition

Expansion of Molecular Diagnostics

Molecular Technologies in IVD—Growth Trends by Segment

Trends Impacting the Molecular Diagnostics Market

Molecular Diagnostics Value Chain—Redefine Patient Care

Molecular Diagnostics—One of the Fastest Growing Segments in the IVD Industry

Promising Factors for the Growth of Molecular Diagnostics in Europe

Key Companies to Watch

Evolution of Science irecting Toward Revolutionizing Molecular Technologies

MDx Action Framework Driving Clinical Decision Making and Betterment in Treatment Provision

Action Framework of MDx in a Testing Scenario

Genomic Biomarker—Defining the MDx Spectrum

Genomic Biomarker—Defining the Diagnostics Spectrum

Workflow of Molecular Diagnostic Techniques

Molecular profiling Across diseases

Parameters Monitoring the Effectiveness of the MDx Platform

New Technologies Overlap Molecular Diagnostics Testing Across Technology

PCR—Gold Standard of Molecular Diagnostics

Key Technologies to Watch

EU Regulatory Bodies for IVD and MDx in European Countries

Reduction of Overall Healthcare Expenditure Toward Early Diagnosis

Healthcare Spending in Europe Rising Faster Than Economic Growth

Market Access Pathways—Molecular Diagnostics

Key Success Criteria in the Molecular Diagnostics Market

Assessing the Value of Molecular Diagnostics in Europe

Major Factors that Govern the Molecular Diagnostics Assessment by HTA Across European Countries

Stepping Stones Promoting Molecular Diagnostics Among the Public With Government Backing

Europe Presents Specific Inter- and Intra-national Heterogeneity in Terms of Diagnostic Reimbursement

Molecular Diagnosis, Resulting in Preventive Rather Than Reactive Healthcare

Entry Barriers to Personalized Medicine in Europe

Market Drivers

Market Restraints

Market Engineering Measurements

Revenue Forecast

Revenue Share by Region

Market Share by Top Competitors

Comparison of Molecular Diagnostic Techniques

Competitor MDx Platforms Available Across Application

NGS Conquering the Future Space of Molecular Diagnostics

The Release of Ilumina’s HiSeq X Ten has Reduced the Cost of Sequencing a Human Genome to US$1,000

Merger, Acquisition, and Partnership Assessment

Revenue Forecast

MDx Platforms Commercially Available for Infectious Diseases

Commercially Available Assay for STI-based Pathogens Across Europe

Revenue Forecast

Emerging Opportunity—Non-invasive Prenatal Testing Across Europe

Revenue Forecast

Paradigm Shifts in Treatment

Implication of Pharmacogenomics

Highest-ranking Barriers to Implementing the Use of Pharmacogenomics Testing in Europe

Revenue Forecast

Uptake of Oncology in Biomarker Testing Across the EU

Implication of Oncology

Market Share Across Technology Segments

Market Share Across Application Segments

Western Europe Molecular Diagnostics Application Segment Metrics Analysis

Western Europe Molecular Diagnostics Technology Segment Metrics Analysis

Revenue Forecast

Revenue Forecast

Revenue Forecast

Revenue Forecast

Revenue Forecast

Revenue Forecast

Revenue Forecast

Roche Diagnostics

Illumina

Cepheid

The Last Word

5 Major Growth Opportunities

Strategic Imperatives for Success and Growth

Conclusion

Legal Disclaimer

Market Engineering Methodology

CE Marked Assays 2015 and 2016

CE Marked Approved Assays 2015 and 2016

Drivers Explained

Restrains Explained

List of Figures
  • 1. Total Molecular Diagnostics Market: Market Trends, Western Europe, 2015
  • 2. Total Molecular Diagnostics Market: MDx Technology Application, Western Europe, 2015
  • 3. Total Molecular Diagnostics Market: Future Key Opportunities and Current Status of MDx, Western Europe, 2015
  • 4. Total Molecular Diagnostics Market: Technology Segmentation, Western Europe, 2015
  • 5. Total Molecular Diagnostics Market: Need for Molecular Diagnostics Across the Patient Continuum, Western Europe, 2015
  • 6. Total Molecular Diagnostics Market: Companies to Watch, Western Europe, 2015
  • 7. Total Molecular Diagnostics Market: Evolution Timeline, Global, 1952–2015
  • 8. Total Molecular Diagnostics Market: Action Framework in Molecular Diagnostics, Western Europe, 2015
  • 9. Total Molecular Diagnostics Market: Action Framework in Molecular Diagnostics, Western Europe, 2015
  • 10. Total Molecular Diagnostics Market: Work Flow, Global, 2015
  • 11. Total Molecular Diagnostics Market: Molecular Profiling—Biomarker Testing, Western Europe, 2015
  • 12. Total Molecular Diagnostics Market: Effectiveness Across Platforms, Global, 2015
  • 13. Total Molecular Diagnostics Market: Overlapping MDx Testing, Global, 2015
  • 14. MDx Technology Polymerase Chain Reaction Variant Comparison, Global, 2015
  • 15. Total Molecular Diagnostics Market: Technologies to Watch, Western Europe , 2015
  • 16. Total Molecular Diagnostics Market: Regulatory Bodies, Western Europe, 2015
  • 17. Total Molecular Diagnostics Market: National Healthcare System, EU, 2015
  • 18. Total Molecular Diagnostics Market: EU 5 Regional Laboratory Facility Norms Inferences, EU, 2015
  • 19. Total Molecular Diagnostics Market: Market Access Pathway, Western Europe, 2015
  • 20. Total Molecular Diagnostics Market: Growth Opportunities in MDx Business Terms, Western Europe, 2015
  • 21. Total Molecular Diagnostics Market: Assay Assessment by HTA, Western Europe, 2015
  • 22. Total Molecular Diagnostics Market: Healthcare Structure, Western Europe, 2015
  • 23. Total Molecular Diagnostics Market: Diagnostics Reimbursement, Europe, 2015
  • 24. Total Molecular Diagnostics Market: MDx in Preventive Healthcare, Western Europe, 2015–2020
  • 25. Total Molecular Diagnostics Market: Policy Making Regulations, Western Europe, 2015
  • 26. Total Molecular Diagnostics Market: Key Market Drivers, Western Europe, 2016–2020
  • 27. Total Molecular Diagnostics Market: Key Market Restraints, Western Europe, 2016–2020
  • 28. Molecular diagnostics Market : Market Engineering Measurements, Western Europe, 2015
  • 29. Total Molecular Diagnostics Market: Pros and Cons of Microarray and FISH, Global, 2015
  • 30. Molecular Diagnostics Market: Pros and cons of NGS and PCR, Global, 2015
  • 31. Total Molecular Diagnostics Market: Competitor Application Platform, Western Europe, 2015
  • 32. Total Molecular Diagnostics Market: Pros and Cons of Various NGS Platforms, Western Europe, 2015
  • 33. Total Molecular Diagnostics Market: Notable Deals and Market Impact, Western Europe, 2015 and 2016
  • 34. Total Molecular Diagnostics Market: Infectious Disease Threat Scenarios, European Union, 2020
  • 35. Total Molecular Diagnostics Market: Currently Available MDx Platforms for Infectious Diseases, Europe, 2015
  • 36. Total Molecular Diagnostics Market: Currently Available Assay for Sexually Transmitted Diseases, Western Europe, 2015
  • 37. Molecular Diagnostics Genetic Testing Market: NIPT Spectrum, Western Europe, 2015
  • 38. Total Molecular Diagnostics Market: Barriers in Pharmacogenomics, Western Europe, 2015
  • 39. Molecular Diagnostics Market: Emerging Molecular Diagnostic Tests Trends in Oncology, Western Europe , 2015
  • 40. Total Molecular Diagnostics Market: Technology Metric Analysis, Western Europe, 2015
  • 41. Total Molecular Diagnostics Market: Application Metric Analysis, Western Europe, 2015
  • 42. Total Molecular Diagnostics Market: Company Profile—Roche Diagnostics, Western Europe, 2015
  • 43. Total Molecular Diagnostics Market: Company Pipeline—Roche Diagnostics, Western Europe, 2015
  • 44. Total Molecular Diagnostics Market: Company Profile—Illumina, Western Europe, 2015
  • 45. Total Molecular Diagnostics Market: Company Profile—Cepheid, Western Europe, 2015
List of Charts
  • 1. Total Molecular Diagnostics Market: Market Engineering Measurements, Western Europe, 2015
  • 2. Total In Vitro Diagnostics Market: Growth by Segment, Western Europe, 2015
  • 3. Total Molecular Diagnostics Market: Growth Factors, Western Europe, 2016–2020 and Beyond
  • 4. IVD Spending Comparison, Germany, 2007 and 2013
  • 5. Total Molecular Diagnostics Market: Revenue Forecast, Western Europe, 2013–2020
  • 6. Total Molecular Diagnostics Market: Percent Revenue by Region, Western Europe, 2015
  • 7. Total Molecular Diagnostics Market: Percent Revenue Breakdown, Western Europe, 2015
  • 8. Molecular Diagnostics Infectious Disease Market: Revenue Forecast, Western Europe, 2013–2020
  • 9. Molecular Diagnostics Genetic Testing Market: Revenue Forecast, Western Europe, 2013–2020
  • 10. Molecular diagnostics Pharmacogenomics Market: Revenue Forecast, Western Europe, 2013–2020
  • 11. Molecular Diagnostics Oncology Market: Revenue Forecast, Western Europe, 2013–2020
  • 12. Total Molecular Diagnostics Market: Percent Revenue Breakdown by Technology, Western Europe, 2015
  • 13. Total Molecular Diagnostics Market: Percent Revenue Breakdown by Application, Western Europe, 2015
  • 14. Molecular Diagnostics Market: Revenue Forecast, The United Kingdom, 2013–2020
  • 15. Molecular Diagnostics Market: Revenue Forecast, Germany, 2013–2020
  • 16. Molecular Diagnostics Market: Revenue Forecast, France, 2013–2020
  • 17. Molecular Diagnostics Market: Revenue Forecast, Italy, 2013–2020
  • 18. Molecular Diagnostics Market: Revenue Forecast, Spain, 2013–2020
  • 19. Molecular Diagnostics Market: Revenue Forecast, Benelux, 2013–2020
  • 20. Molecular Diagnostics Market: Revenue Forecast, Scandinavia, 2013–2020
Request Sample
Popular Topics

genomics market

electric vehicle market analysis

biocides market

smart wearables market

solar energy market

power electronics market

residential solar market

smart meter market

emulsifier market

aerospace industry outlook

Across the In vitro diagnostics Segment , including research and further upcoming disruptive technologies Across the Life Sciences landscape, including research tools, clinical diagnostics and pharma, disruptive technologies transform the complete the Healthcare decision making , and diagnostics trend . However, to take advantage of these opportunities and maintain a competitive advantage, life science companies must be able to develop a thorough holistic understanding of areas outside of their own expertise to leverage the cross-functional trends and synergistic growth opportunities that are available. Molecular diagnostics Companies who fail to capitalize on opportunities presented through emerging trends and disruptive new business models become late entrants in a market that generally before redundancy from me-too products occurs and takes market share. This report is an elaborate structure of the European Healthcare system , which is supporting the growth of Molecular diagnostics , the reimbursement strategies and policies promoting the acceptance of MDx assays across application , This information would be suitable to understand the current need and the diagnostics style adaptation among the patient population for better outcome and clinical decision making. Specific challenges shared in this report include shifting payment landscape (business models) who pays for services, challenge monetize Innovative Therapeutics & Molecular Diagnostics to align with Value based Care Models
More Information
No Index No
Podcast No
Table of Contents | Executive Summary~ || Market Snapshot~ || Executive summary~ || Scope and Segmentation~ || Executive Summary—Market Engineering Measurements~ || Big Market Directions in Molecular Diagnostics~ | Market Overview~ || Market Definition~ || Expansion of Molecular Diagnostics~ || Molecular Technologies in IVD—Growth Trends by Segment~ || Trends Impacting the Molecular Diagnostics Market~ || Molecular Diagnostics Value Chain—Redefine Patient Care~ || Molecular Diagnostics—One of the Fastest Growing Segments in the IVD Industry~ || Promising Factors for the Growth of Molecular Diagnostics in Europe~ || Key Companies to Watch~ | Technology Overview~ || Evolution of Science irecting Toward Revolutionizing Molecular Technologies~ || MDx Action Framework Driving Clinical Decision Making and Betterment in Treatment Provision~ || Action Framework of MDx in a Testing Scenario~ || Genomic Biomarker—Defining the MDx Spectrum~ || Genomic Biomarker—Defining the Diagnostics Spectrum~ || Workflow of Molecular Diagnostic Techniques~ || Molecular profiling Across diseases~ || Parameters Monitoring the Effectiveness of the MDx Platform~ || New Technologies Overlap Molecular Diagnostics Testing Across Technology~ || PCR—Gold Standard of Molecular Diagnostics~ || Key Technologies to Watch~ | European Molecular Diagnostics Market Dynamics~ || EU Regulatory Bodies for IVD and MDx in European Countries~ || Reduction of Overall Healthcare Expenditure Toward Early Diagnosis~ || Healthcare Spending in Europe Rising Faster Than Economic Growth~ || Market Access Pathways—Molecular Diagnostics~ || Key Success Criteria in the Molecular Diagnostics Market~ || Assessing the Value of Molecular Diagnostics in Europe~ || Major Factors that Govern the Molecular Diagnostics Assessment by HTA Across European Countries~ || Stepping Stones Promoting Molecular Diagnostics Among the Public With Government Backing~ || Europe Presents Specific Inter- and Intra-national Heterogeneity in Terms of Diagnostic Reimbursement~ || Molecular Diagnosis, Resulting in Preventive Rather Than Reactive Healthcare~ || Entry Barriers to Personalized Medicine in Europe~ | Drivers and Restrains—Total Molecular Diagnostics Market~ || Market Drivers~ || Market Restraints~ | Forecasts and Trends—Total Molecular Diagnostics Market~ || Market Engineering Measurements~ || Revenue Forecast~ || Revenue Share by Region~ | Competitive Landscape~ || Market Share by Top Competitors~ || Comparison of Molecular Diagnostic Techniques~ || Competitor MDx Platforms Available Across Application~ || NGS Conquering the Future Space of Molecular Diagnostics~ || The Release of Ilumina’s HiSeq X Ten has Reduced the Cost of Sequencing a Human Genome to US$1,000~ | Mergers and Acquisitions~ || Merger, Acquisition, and Partnership Assessment~ | Molecular Diagnostics Infectious Disease Market Analysis~ || Revenue Forecast~ || MDx Platforms Commercially Available for Infectious Diseases~ || Commercially Available Assay for STI-based Pathogens Across Europe~ | Genetic Testing Market Analysis~ || Revenue Forecast~ || Emerging Opportunity—Non-invasive Prenatal Testing Across Europe~ | Pharmacogenomics Market Analysis~ || Revenue Forecast~ || Paradigm Shifts in Treatment~ || Implication of Pharmacogenomics~ || Highest-ranking Barriers to Implementing the Use of Pharmacogenomics Testing in Europe~ | Oncology Market Analysis~ || Revenue Forecast~ || Uptake of Oncology in Biomarker Testing Across the EU~ || Implication of Oncology~ | Molecular Diagnostics Segment-wise Market Analysis~ || Market Share Across Technology Segments~ || Market Share Across Application Segments~ || Western Europe Molecular Diagnostics Application Segment Metrics Analysis~ || Western Europe Molecular Diagnostics Technology Segment Metrics Analysis~ | The United Kingdom Analysis~ || Revenue Forecast~ | Germany Analysis~ || Revenue Forecast~ | France Analysis~ || Revenue Forecast~ | Italy Analysis~ || Revenue Forecast~ | Spain Analysis~ || Revenue Forecast~ | Benelux Analysis~ || Revenue Forecast~ | Scandinavia Analysis~ || Revenue Forecast~ | Key Participants~ || Roche Diagnostics~ || Illumina~ || Cepheid~ || The Last Word~ || 5 Major Growth Opportunities~ || Strategic Imperatives for Success and Growth~ | Last Word~ || Conclusion~ || Legal Disclaimer~ || Market Engineering Methodology~ | Appendix~ | List of Companies~ | CE Marked Approved Assays~ || CE Marked Assays 2015 and 2016~ || CE Marked Approved Assays 2015 and 2016~ || Drivers Explained~ || Restrains Explained~
List of Charts and Figures 1. Total Molecular Diagnostics Market: Market Trends, Western Europe, 2015~ 2. Total Molecular Diagnostics Market: MDx Technology Application, Western Europe, 2015~ 3. Total Molecular Diagnostics Market: Future Key Opportunities and Current Status of MDx, Western Europe, 2015~ 4. Total Molecular Diagnostics Market: Technology Segmentation, Western Europe, 2015~ 5. Total Molecular Diagnostics Market: Need for Molecular Diagnostics Across the Patient Continuum, Western Europe, 2015~ 6. Total Molecular Diagnostics Market: Companies to Watch, Western Europe, 2015~ 7. Total Molecular Diagnostics Market: Evolution Timeline, Global, 1952–2015~ 8. Total Molecular Diagnostics Market: Action Framework in Molecular Diagnostics, Western Europe, 2015~ 9. Total Molecular Diagnostics Market: Action Framework in Molecular Diagnostics, Western Europe, 2015~ 10. Total Molecular Diagnostics Market: Work Flow, Global, 2015~ 11. Total Molecular Diagnostics Market: Molecular Profiling—Biomarker Testing, Western Europe, 2015~ 12. Total Molecular Diagnostics Market: Effectiveness Across Platforms, Global, 2015~ 13. Total Molecular Diagnostics Market: Overlapping MDx Testing, Global, 2015~ 14. MDx Technology Polymerase Chain Reaction Variant Comparison, Global, 2015~ 15. Total Molecular Diagnostics Market: Technologies to Watch, Western Europe , 2015~ 16. Total Molecular Diagnostics Market: Regulatory Bodies, Western Europe, 2015~ 17. Total Molecular Diagnostics Market: National Healthcare System, EU, 2015~ 18. Total Molecular Diagnostics Market: EU 5 Regional Laboratory Facility Norms Inferences, EU, 2015 ~ 19. Total Molecular Diagnostics Market: Market Access Pathway, Western Europe, 2015~ 20. Total Molecular Diagnostics Market: Growth Opportunities in MDx Business Terms, Western Europe, 2015~ 21. Total Molecular Diagnostics Market: Assay Assessment by HTA, Western Europe, 2015~ 22. Total Molecular Diagnostics Market: Healthcare Structure, Western Europe, 2015~ 23. Total Molecular Diagnostics Market: Diagnostics Reimbursement, Europe, 2015~ 24. Total Molecular Diagnostics Market: MDx in Preventive Healthcare, Western Europe, 2015–2020~ 25. Total Molecular Diagnostics Market: Policy Making Regulations, Western Europe, 2015~ 26. Total Molecular Diagnostics Market: Key Market Drivers, Western Europe, 2016–2020~ 27. Total Molecular Diagnostics Market: Key Market Restraints, Western Europe, 2016–2020~ 28. Molecular diagnostics Market : Market Engineering Measurements, Western Europe, 2015~ 29. Total Molecular Diagnostics Market: Pros and Cons of Microarray and FISH, Global, 2015~ 30. Molecular Diagnostics Market: Pros and cons of NGS and PCR, Global, 2015~ 31. Total Molecular Diagnostics Market: Competitor Application Platform, Western Europe, 2015 ~ 32. Total Molecular Diagnostics Market: Pros and Cons of Various NGS Platforms, Western Europe, 2015~ 33. Total Molecular Diagnostics Market: Notable Deals and Market Impact, Western Europe, 2015 and 2016~ 34. Total Molecular Diagnostics Market: Infectious Disease Threat Scenarios, European Union, 2020~ 35. Total Molecular Diagnostics Market: Currently Available MDx Platforms for Infectious Diseases, Europe, 2015~ 36. Total Molecular Diagnostics Market: Currently Available Assay for Sexually Transmitted Diseases, Western Europe, 2015~ 37. Molecular Diagnostics Genetic Testing Market: NIPT Spectrum, Western Europe, 2015~ 38. Total Molecular Diagnostics Market: Barriers in Pharmacogenomics, Western Europe, 2015 ~ 39. Molecular Diagnostics Market: Emerging Molecular Diagnostic Tests Trends in Oncology, Western Europe , 2015~ 40. Total Molecular Diagnostics Market: Technology Metric Analysis, Western Europe, 2015 ~ 41. Total Molecular Diagnostics Market: Application Metric Analysis, Western Europe, 2015 ~ 42. Total Molecular Diagnostics Market: Company Profile—Roche Diagnostics, Western Europe, 2015~ 43. Total Molecular Diagnostics Market: Company Pipeline—Roche Diagnostics, Western Europe, 2015~ 44. Total Molecular Diagnostics Market: Company Profile—Illumina, Western Europe, 2015~ 45. Total Molecular Diagnostics Market: Company Profile—Cepheid, Western Europe, 2015~| 1. Total Molecular Diagnostics Market: Market Engineering Measurements, Western Europe, 2015~ 2. Total In Vitro Diagnostics Market: Growth by Segment, Western Europe, 2015~ 3. Total Molecular Diagnostics Market: Growth Factors, Western Europe, 2016–2020 and Beyond~ 4. IVD Spending Comparison, Germany, 2007 and 2013~ 5. Total Molecular Diagnostics Market: Revenue Forecast, Western Europe, 2013–2020~ 6. Total Molecular Diagnostics Market: Percent Revenue by Region, Western Europe, 2015~ 7. Total Molecular Diagnostics Market: Percent Revenue Breakdown, Western Europe, 2015 ~ 8. Molecular Diagnostics Infectious Disease Market: Revenue Forecast, Western Europe, 2013–2020~ 9. Molecular Diagnostics Genetic Testing Market: Revenue Forecast, Western Europe, 2013–2020~ 10. Molecular diagnostics Pharmacogenomics Market: Revenue Forecast, Western Europe, 2013–2020~ 11. Molecular Diagnostics Oncology Market: Revenue Forecast, Western Europe, 2013–2020~ 12. Total Molecular Diagnostics Market: Percent Revenue Breakdown by Technology, Western Europe, 2015~ 13. Total Molecular Diagnostics Market: Percent Revenue Breakdown by Application, Western Europe, 2015~ 14. Molecular Diagnostics Market: Revenue Forecast, The United Kingdom, 2013–2020~ 15. Molecular Diagnostics Market: Revenue Forecast, Germany, 2013–2020~ 16. Molecular Diagnostics Market: Revenue Forecast, France, 2013–2020~ 17. Molecular Diagnostics Market: Revenue Forecast, Italy, 2013–2020~ 18. Molecular Diagnostics Market: Revenue Forecast, Spain, 2013–2020~ 19. Molecular Diagnostics Market: Revenue Forecast, Benelux, 2013–2020~ 20. Molecular Diagnostics Market: Revenue Forecast, Scandinavia, 2013–2020~
Author Mohamed Sulaikha
WIP Number MC62-01-00-00-00
Is Prebook No